NIH finds neuroscience director engaged in research misconduct
Click Here to Manage Email Alerts
The NIH announced that Eliezer Masliah, MD, now former director of the division of neuroscience at the National Institute on Aging, engaged in research misconduct while serving in the agency.
The NIH said in a statement that Masliah committed falsification and/or fabrication involving repeated use and relabeling of “figure panels representing different experimental results in two publications.”
The NIH further stated it will notify the two journals in which the panels appeared of its findings so that appropriate action can be taken.
The agency initiated a research misconduct review process in May 2023 after it was notified of allegations from the HHS Office of Research Integrity. An investigation was subsequently initiated in December 2023 and concluded on Sept. 15.
Masliah joined the NIH in 2016 as director of the division of neuroscience at the National Institute on Aging (NIA) and an intramural researcher studying synaptic damage in patients with neurodegenerative disorders. Per the NIH, he no longer serves as director. NIA Deputy Director Amy Kelley, MD, has assumed the role of acting director.
The NIH declined to comment further when asked about details surrounding its decision.